China's Lithium Giants Tumble After First-Half Profit Warnings
Tianqi Lithium Corp. forecast a negligible net income of up to 155 million yuan ($21.6 million) for the first six months, while Ganfeng Lithium Group Co. predicted a net loss of 300 million yuan to 550 million yuan for the same period. Chengxin Lithium Group Co. said its net loss could be as high as 850 million yuan.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Things Look Grim For Senior plc (LON:SNR) After Today's Downgrade
Explore Senior's Fair Values from the Community and select yours Market forces rained on the parade of Senior plc (LON:SNR) shareholders today, when the analysts downgraded their forecasts for this year. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting analysts have soured majorly on the business. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Following the latest downgrade, the four analysts covering Senior provided consensus estimates of UK£833m revenue in 2025, which would reflect a chunky 16% decline on its sales over the past 12 months. Statutory earnings per share are anticipated to decline 11% to UK£0.068 in the same period. Prior to this update, the analysts had been forecasting revenues of UK£1.1b and earnings per share (EPS) of UK£0.092 in 2025. Indeed, we can see that the analysts are a lot more bearish about Senior's prospects, administering a pretty serious reduction to revenue estimates and slashing their EPS estimates to boot. View our latest analysis for Senior What's most unexpected is that the consensus price target rose 13% to UK£2.24, strongly implying the downgrade to forecasts is not expected to be more than a temporary blip. One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that sales are expected to reverse, with a forecast 29% annualised revenue decline to the end of 2025. That is a notable change from historical growth of 6.0% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 7.3% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Senior is expected to lag the wider industry. The Bottom Line The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Senior. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Senior's revenues are expected to grow slower than the wider market. The rising price target is a puzzle, but still - with a serious cut to this year's outlook, we wouldn't be surprised if investors were a bit wary of Senior. Still, the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Senior going out to 2027, and you can see them free on our platform here. Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
33 minutes ago
- Yahoo
Primo Brands Second Quarter 2025 Earnings: Misses Expectations
Explore Primo Brands's Fair Values from the Community and select yours Primo Brands (NYSE:PRMB) Second Quarter 2025 Results Key Financial Results Revenue: US$1.73b (up 32% from 2Q 2024). Net income: US$30.5m (down 44% from 2Q 2024). Profit margin: 1.8% (down from 4.1% in 2Q 2024). EPS: US$0.081 (down from US$52.89 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Primo Brands Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 4.7%. Earnings per share (EPS) also missed analyst estimates by 83%. Looking ahead, revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Beverage industry in the US. Performance of the American Beverage industry. The company's shares are down 12% from a week ago. Risk Analysis We should say that we've discovered 2 warning signs for Primo Brands (1 shouldn't be ignored!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Up 10% in a week, is this FTSE 100 stock set to be the comeback story of 2025?
Diageo (LSE:DGE) shares are up 10% since the firm released its full-year earnings on Monday (4 August). I own shares in the FTSE 100 drinks company and I thought the results were… fine. Importantly though, both the firm's results and its forward guidance were ahead of analyst expectations. And a lot of the time, this is what makes share prices move in the short term. The results In the 12 months leading up to 30 June, Diageo reported organic sales growth of 1.7%, while earnings per share fell 0.7% due to increased investments in facilities. Neither of these numbers are particularly inspiring, but both are ahead of what analysts had been expecting. And that's part of the reason the stock's responded positively. The company's forward-looking guidance was much more positive. Diageo expects similar sales growth in 2026, but is looking to make a series of cost cuts, which should lead to 5% profit growth. This is very clearly better than investors had anticipated, but it's worth keeping things in context. And to be fair, the market's doing this – the stock's still down 22% since the start of the year. Not the end Until February, Diageo's official medium-term guidance was for organic revenue growth to be in the region of 6%. And with the firm set to achieve 1.7% again next year, that seems a long way off. Furthermore, while the plan to reduce costs might be a good one, it's not really a strategy for long-term growth. There's only so much cost-cutting to boost profits any business can do. After the Second Battle of El Alamein, Winston Churchill famously said: 'This is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning'. That's pretty much my view on Diageo at the moment. The business is a long way off where I might have hoped it would be, but it is – at least – starting to show signs of arresting the decline. Valuation Diageo's a fascinating stock. When things are going well, investors focus on its obvious strengths, but when they start to go wrong, the market sees nothing but threats. The truth – as is often the case – is probably somewhere in the middle. The FTSE 100 firm's brands and scale are a genuine strength, but GLP-1 drugs are also a very real challenge. That means the trick when it comes to buying the stock is to try and work out when investors are pessimistic and focusing on the negatives. That's when the shares trade at attractive prices. Despite the share price climbing 10% in the last week, I think this is still the case. A price-to-earnings (P/E) ratio of 16 is towards the lower end of where the stock has traded over the last five years. The comeback story of 2025? Diageo's set out a clear agenda for growth over the next 12 months. And this was definitely a positive surprise for the stock market, which is why the share price has jumped. I don't think the stock's going to be the comeback story of 2025. But I'm optimistic this might be the year when the company manages to stop the downturn of the last few years. I feel it's worth watching. The post Up 10% in a week, is this FTSE 100 stock set to be the comeback story of 2025? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Stephen Wright has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
